Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

encenicline

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Inattention is a disabling symptom in conditions such as schizophrenia and attention deficit/hyperactivity disorder. Nicotine can… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2016
Review
2016
Alzheimer's disease (AD) is considered to be the most common cause of dementia and is an incurable, progressive neurodegenerative… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2016
2016
The α7 pentamer nicotinic acetylcholine receptors (nAChRs) are a target in transduction of anti-inflammatory signals from the… Expand
Highly Cited
2015
Highly Cited
2015
Encenicline is a novel, selective α7 nicotinic acetylcholine receptor agonist in development for treating cognitive impairment in… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
2015
2015
PURPOSE Encenicline (EVP-6124) is a selective α7 nicotinic acetylcholine receptor partial agonist being developed for cognitive… Expand
  • table I
  • table II
  • figure 1
  • figure 2
  • table III
Review
2015
Review
2015
Alzheimer’s disease (AD) is a prevalent and currently incurable brain disease whose impact will continue to rise as the… Expand
2015
2015
Cognitive functioning can be assessed with performance-based assessments such as neuropsychological tests and with interview… Expand
Review
2015
Review
2015
  • K. Hashimoto
  • Current pharmaceutical design
  • 2015
  • Corpus ID: 3012876
Accumulating evidence suggests that the α7 subtype of nicotinic acetylcholine receptors (nAChRs) plays a key role in inflammatory… Expand
2015
2015
Pharmacological activation of α7 nicotinic acetylcholine receptors (α7 nAChRs) may improve cognition in schizophrenia and… Expand
Review
2014
Review
2014
  • L. Citrome
  • The Journal of clinical psychiatry
  • 2014
  • Corpus ID: 20705056
Current treatments for schizophrenia, although effective for positive symptoms, have not proven as effective for negative… Expand